The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats

Objective. To investigate the effect of beraprost sodium (BPS) on diabetic cardiomyopathy and the underlying mechanism. Methods. A total of 40 Sprague Dawley rats were randomly divided into the normal control group (N=10) and the model group (N=30). The model group was fed a high-fat diet followed b...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Li, Li Peng, Hong Du, Yangtian Wang, Bin Lu, Yixin Xu, Xiaozhen Ye, Jiaqing Shao
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2014/901437
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560453187796992
author Jie Li
Li Peng
Hong Du
Yangtian Wang
Bin Lu
Yixin Xu
Xiaozhen Ye
Jiaqing Shao
author_facet Jie Li
Li Peng
Hong Du
Yangtian Wang
Bin Lu
Yixin Xu
Xiaozhen Ye
Jiaqing Shao
author_sort Jie Li
collection DOAJ
description Objective. To investigate the effect of beraprost sodium (BPS) on diabetic cardiomyopathy and the underlying mechanism. Methods. A total of 40 Sprague Dawley rats were randomly divided into the normal control group (N=10) and the model group (N=30). The model group was fed a high-fat diet followed by a one-time dose of streptozotocin (STZ) to establish the diabetes mellitus model. After that, rats were randomly divided into two groups with or without BPS intervention. After 8 weeks, we explored the role of the p38 MAPK signaling pathway in inflammation, oxidative stress, cardiac morphology, and myocardial apoptosis. Results. Compared with control, the ratio of heart-weight to body-weight and the serum levels of SOD and GSH in the BPS group significantly increased, the expression of p38 MAPK, the serum levels of MDA, TGF-β1, TNF-α, HIF-1α, MMP-9, caspase-3, BNP, ANP, and heart Bax expression significantly decreased, and heart Bcl-2 expression significantly increased. H&E staining in diabetic rats showed the cardiac muscle fibers derangement, the widening gap, the pyknotic and fragmented nuclei, and more apoptosis. Conclusions. BPS effectively showed protective effects on diabetic myocardial cells, possibly through the inhibition of p38 MAPK signaling pathway.
format Article
id doaj-art-c90521aa374a4e488071f8b78baa237f
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-c90521aa374a4e488071f8b78baa237f2025-02-03T01:27:35ZengWileyInternational Journal of Endocrinology1687-83371687-83452014-01-01201410.1155/2014/901437901437The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD RatsJie Li0Li Peng1Hong Du2Yangtian Wang3Bin Lu4Yixin Xu5Xiaozhen Ye6Jiaqing Shao7Department of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaDepartment of Endocrinology, Jinling Hospital, Medical School of Nanjing University, 305 East Zhongshan Road, Nanjing, Jiangsu 210002, ChinaObjective. To investigate the effect of beraprost sodium (BPS) on diabetic cardiomyopathy and the underlying mechanism. Methods. A total of 40 Sprague Dawley rats were randomly divided into the normal control group (N=10) and the model group (N=30). The model group was fed a high-fat diet followed by a one-time dose of streptozotocin (STZ) to establish the diabetes mellitus model. After that, rats were randomly divided into two groups with or without BPS intervention. After 8 weeks, we explored the role of the p38 MAPK signaling pathway in inflammation, oxidative stress, cardiac morphology, and myocardial apoptosis. Results. Compared with control, the ratio of heart-weight to body-weight and the serum levels of SOD and GSH in the BPS group significantly increased, the expression of p38 MAPK, the serum levels of MDA, TGF-β1, TNF-α, HIF-1α, MMP-9, caspase-3, BNP, ANP, and heart Bax expression significantly decreased, and heart Bcl-2 expression significantly increased. H&E staining in diabetic rats showed the cardiac muscle fibers derangement, the widening gap, the pyknotic and fragmented nuclei, and more apoptosis. Conclusions. BPS effectively showed protective effects on diabetic myocardial cells, possibly through the inhibition of p38 MAPK signaling pathway.http://dx.doi.org/10.1155/2014/901437
spellingShingle Jie Li
Li Peng
Hong Du
Yangtian Wang
Bin Lu
Yixin Xu
Xiaozhen Ye
Jiaqing Shao
The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
International Journal of Endocrinology
title The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
title_full The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
title_fullStr The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
title_full_unstemmed The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
title_short The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
title_sort protective effect of beraprost sodium on diabetic cardiomyopathy through the inhibition of the p38 mapk signaling pathway in high fat induced sd rats
url http://dx.doi.org/10.1155/2014/901437
work_keys_str_mv AT jieli theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT lipeng theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT hongdu theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT yangtianwang theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT binlu theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT yixinxu theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT xiaozhenye theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT jiaqingshao theprotectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT jieli protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT lipeng protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT hongdu protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT yangtianwang protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT binlu protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT yixinxu protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT xiaozhenye protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats
AT jiaqingshao protectiveeffectofberaprostsodiumondiabeticcardiomyopathythroughtheinhibitionofthep38mapksignalingpathwayinhighfatinducedsdrats